Tandem's Predictive Technologies: Pediatric Pivotal Trial of Control-IQ Technology in Children with Type 1 Diabetes
Originally broadcast on February 16, 2021, Betsy Dokken, NP, PhD, Director of Clinical Affairs at Tandem Diabetes Care, presented the results from the pediatric pivotal trial (DCLP5) data published in the New England Journal of Medicine (NEJM): A Randomized Control of Closed-Loop Control in Children with Type 1 Diabetes.
This webinar covered the study results of the pivotal trial and a pediatric case study. The presentation was followed by a speaker Q&A.
Enter your information and you’ll receive an email with a link to view the webinar.